G. Subramanian

2.1k total citations
54 papers, 1.6k citations indexed

About

G. Subramanian is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, G. Subramanian has authored 54 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Radiology, Nuclear Medicine and Imaging, 24 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in G. Subramanian's work include Radiopharmaceutical Chemistry and Applications (22 papers), Medical Imaging and Pathology Studies (20 papers) and Medical Imaging Techniques and Applications (7 papers). G. Subramanian is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (22 papers), Medical Imaging and Pathology Studies (20 papers) and Medical Imaging Techniques and Applications (7 papers). G. Subramanian collaborates with scholars based in India and United States. G. Subramanian's co-authors include J.G. McAfee, Richard Blair, F.D. Thomas, B. J. Northover, Francis A. Kallfelz, Robert E. O’Mara, R. Arnold, Z GROSSMAN, Howard S. Stern and M. P. Antony and has published in prestigious journals such as Radiology, Radiographics and Thermochimica Acta.

In The Last Decade

G. Subramanian

53 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Subramanian India 21 750 629 372 267 96 54 1.6k
J.G. McAfee United States 23 1000 1.3× 788 1.3× 409 1.1× 432 1.6× 138 1.4× 69 1.9k
R. G. Bessent United Kingdom 25 407 0.5× 355 0.6× 846 2.3× 553 2.1× 85 0.9× 81 1.9k
Eugene L. Saenger United States 21 711 0.9× 317 0.5× 224 0.6× 363 1.4× 108 1.1× 91 1.7k
David C. Price United States 29 743 1.0× 434 0.7× 339 0.9× 1.0k 3.9× 367 3.8× 94 3.1k
Edward B. Silberstein United States 31 1.0k 1.4× 691 1.1× 564 1.5× 902 3.4× 279 2.9× 129 3.0k
Wan‐Yu Lin Taiwan 21 560 0.7× 360 0.6× 187 0.5× 282 1.1× 78 0.8× 105 1.4k
Judith A. W. Webb United Kingdom 18 824 1.1× 605 1.0× 117 0.3× 376 1.4× 91 0.9× 34 2.5k
S Ebbe United States 22 180 0.2× 358 0.6× 158 0.4× 128 0.5× 232 2.4× 73 1.7k
Z.H. Oster United States 16 523 0.7× 263 0.4× 158 0.4× 285 1.1× 155 1.6× 68 1.2k
F M Hall United Kingdom 19 197 0.3× 155 0.2× 111 0.3× 347 1.3× 38 0.4× 65 1.1k

Countries citing papers authored by G. Subramanian

Since Specialization
Citations

This map shows the geographic impact of G. Subramanian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Subramanian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Subramanian more than expected).

Fields of papers citing papers by G. Subramanian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Subramanian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Subramanian. The network helps show where G. Subramanian may publish in the future.

Co-authorship network of co-authors of G. Subramanian

This figure shows the co-authorship network connecting the top 25 collaborators of G. Subramanian. A scholar is included among the top collaborators of G. Subramanian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Subramanian. G. Subramanian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nayak, Prasant Kumar, R. Kumaresan, K. A. Venkatesan, et al.. (2014). Studies on the Radiochemical Degradation of Tetraethylhexyl Diglycolamide and Ethylhexylphosphoric Acid in n -Dodecane Solution. Separation Science and Technology. 50(5). 646–653. 3 indexed citations
2.
Nayak, Prasant Kumar, R. Kumaresan, K. A. Venkatesan, et al.. (2013). Single-cycle separation of americium (III) from simulated high-level liquid waste using tetra-bis(2-ethylhexyl)diglycolamide and bis(2-ethylhexyl)phosphoric acid solution. Journal of environmental chemical engineering. 1(3). 559–565. 22 indexed citations
3.
McAfee, J.G., et al.. (1989). Comparison of different radioactive renal agents in cisplatin-induced tubular toxicity in rats.. PubMed. 30(5). 659–65. 1 indexed citations
4.
McAfee, J.G., et al.. (1988). Evaluation of cyclosporine nephrotoxicity in rats with various renal radioactive agents.. PubMed. 29(9). 1577–81. 1 indexed citations
5.
6.
GROSSMAN, Z, et al.. (1987). Aged venous thrombi: radioimmunoimaging with fibrin-specific monoclonal antibody.. Radiology. 162(2). 575–577. 30 indexed citations
7.
McAfee, John G., et al.. (1986). Monoclonal antibody against human fibrin for imaging thrombi. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 13(6). 669–669. 1 indexed citations
8.
GROSSMAN, Z, et al.. (1985). Imaging of fresh and aged venous thrombi in the dog with I-131 monoclonal antibody specific for the NH/sub 2/-terminal region of fibrin. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 2 indexed citations
9.
McAfee, J.G., et al.. (1985). Technetium-99m DADS complexes as renal function and imaging agents: II. Biological comparison with iodine-131 hippuran.. PubMed. 26(4). 375–84. 18 indexed citations
10.
Kudryk, B, et al.. (1985). Radioimmunoimaging of venous thrombi using iodine-131 monoclonal antibody.. Radiology. 156(2). 515–517. 43 indexed citations
11.
McAfee, John G. & G. Subramanian. (1983). Interpretation of interspecies differences in the biodistribution of radioactive agents. International Journal of Nuclear Medicine and Biology. 10(1). 48–48. 1 indexed citations
12.
Subramanian, G., et al.. (1978). Platelets labeled with oxine complexes of Tc-99m and In-111. Part 2. Localization of experimentally induced vascular lesions.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 19(5). 488–91. 37 indexed citations
13.
Wistow, Brian W., G. Subramanian, G. Gagne, et al.. (1978). Experimental and clinical trials of new /sub 99m/Tc-labeled hepatobiliary agents. [Iminodiacetic acid derivatives]. Radiology. 2 indexed citations
14.
Subramanian, G., et al.. (1975). Technetium-99m-labeled stannous imidodiphosphate, a new radiodiagnostic agent for bone scanning: comparison with other 99mTc complexes.. PubMed. 16(12). 1137–43. 18 indexed citations
15.
Subramanian, G., et al.. (1972). 99m Tc-EHDP: a potential radiopharmaceutical for skeletal imaging.. PubMed. 13(12). 947–50. 55 indexed citations
16.
Subramanian, G., et al.. (1972). 99mTc-Labeled Polyphosphate as a Skeletal Imaging Agent. Radiology. 102(3). 701–704. 129 indexed citations
17.
Subramanian, G., et al.. (1971). Nonneoplastic localization of gallium 67 citrate. 12(6). 338–339. 21 indexed citations
18.
Stern, Howard S., J.G. McAfee, & G. Subramanian. (1966). Preparation, distribution and utilization of technetium-99m-sulfur colloid.. PubMed. 7(9). 665–75. 55 indexed citations
19.
Northover, B. J. & G. Subramanian. (1962). A STUDY OF POSSIBLE MEDIATORS OF INFLAMMATORY REACTIONS IN THE MOUSE FOOT. British Journal of Pharmacology and Chemotherapy. 18(2). 346–355. 10 indexed citations
20.
Northover, B. J. & G. Subramanian. (1961). ANALGESIC‐ANTIPYRETIC DRUGS AS INHIBITORS OF KALLIKREIN. British Journal of Pharmacology and Chemotherapy. 17(1). 107–115. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026